These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 17383162

  • 1. Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain.
    Weikop P, Yoshitake T, Kehr J.
    Eur Neuropsychopharmacol; 2007 Oct; 17(10):658-71. PubMed ID: 17383162
    [Abstract] [Full Text] [Related]

  • 2. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P, Kehr J, Scheel-Krüger J.
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [Abstract] [Full Text] [Related]

  • 3. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T.
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [Abstract] [Full Text] [Related]

  • 4. Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline.
    Millan MJ, Gobert A, Girardon S, Dekeyne A.
    Eur J Pharmacol; 1999 Jan 08; 364(2-3):147-50. PubMed ID: 9932717
    [Abstract] [Full Text] [Related]

  • 5. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram.
    Pozzi L, Invernizzi R, Garavaglia C, Samanin R.
    J Neurochem; 1999 Sep 08; 73(3):1051-7. PubMed ID: 10461894
    [Abstract] [Full Text] [Related]

  • 6. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE, Gonzalez-Lira V, Horrillo I, Herrera-Marschitz M, Callado LF, Meana JJ.
    Eur J Pharmacol; 2013 Jun 05; 709(1-3):13-9. PubMed ID: 23562616
    [Abstract] [Full Text] [Related]

  • 7. The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.
    Montezinho LP, Miller S, Plath N, Jensen NH, Karlsson JJ, Witten L, Mørk A.
    Psychopharmacology (Berl); 2010 Oct 05; 212(2):131-43. PubMed ID: 20676614
    [Abstract] [Full Text] [Related]

  • 8. Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats.
    Umehara M, Ago Y, Fujita K, Hiramatsu N, Takuma K, Matsuda T.
    Eur J Pharmacol; 2013 Feb 28; 702(1-3):250-7. PubMed ID: 23376565
    [Abstract] [Full Text] [Related]

  • 9. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
    Kitaichi Y, Inoue T, Izumi T, Nakagawa S, Tanaka T, Masui T, Koyama T.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):285-90. PubMed ID: 18336812
    [Abstract] [Full Text] [Related]

  • 10. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
    Invernizzi R, Velasco C, Bramante M, Longo A, Samanin R.
    Neuropharmacology; 1997 Apr 28; 36(4-5):467-73. PubMed ID: 9225271
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
    Björkholm C, Frånberg O, Malmerfelt A, Marcus MM, Konradsson-Geuken Å, Schilström B, Jardemark K, Svensson TH.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(3):. PubMed ID: 25522408
    [Abstract] [Full Text] [Related]

  • 12. Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: in vivo microdialysis study.
    Muraki I, Inoue T, Hashimoto S, Izumi T, Koyama T.
    Psychiatry Clin Neurosci; 2008 Oct 31; 62(5):568-74. PubMed ID: 18950377
    [Abstract] [Full Text] [Related]

  • 13. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
    Gobert A, Brocco M, Dekeyne A, Di Cara B, Bouchez G, Lejeune F, Gannon RL, Millan MJ.
    Neuropsychopharmacology; 2009 Mar 31; 34(4):1039-56. PubMed ID: 18830239
    [Abstract] [Full Text] [Related]

  • 14. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.
    Bari A, Eagle DM, Mar AC, Robinson ES, Robbins TW.
    Psychopharmacology (Berl); 2009 Aug 31; 205(2):273-83. PubMed ID: 19404616
    [Abstract] [Full Text] [Related]

  • 15. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
    Weikop P, Kehr J, Scheel-Krüger J.
    J Psychopharmacol; 2004 Sep 31; 18(3):395-403. PubMed ID: 15358984
    [Abstract] [Full Text] [Related]

  • 16. CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex.
    Kleijn J, Cremers TI, Hofland CM, Westerink BH.
    Neurosci Res; 2011 Jul 31; 70(3):334-7. PubMed ID: 21420449
    [Abstract] [Full Text] [Related]

  • 17. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.
    Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kakuta A, Izumi T, Koyama T.
    Eur J Pharmacol; 2010 Nov 25; 647(1-3):90-6. PubMed ID: 20816814
    [Abstract] [Full Text] [Related]

  • 18. Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline-rich isocortical but not prefrontal areas: dependence on serotonin-1A receptors and independence from noradrenergic innervation.
    Valentini V, Cacciapaglia F, Frau R, Di Chiara G.
    J Neurochem; 2005 Apr 25; 93(2):371-82. PubMed ID: 15816860
    [Abstract] [Full Text] [Related]

  • 19. Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.
    Navailles S, Bioulac B, Gross C, De Deurwaerdère P.
    Neurobiol Dis; 2010 Apr 25; 38(1):136-43. PubMed ID: 20096781
    [Abstract] [Full Text] [Related]

  • 20. Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity.
    Golembiowska K, Kowalska M, Bymaster FP.
    Synapse; 2012 May 25; 66(5):435-44. PubMed ID: 22213370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.